As the effects of sildenafil are in part mediated by enhancing the action of nitric oxide and nitrates given acutely markedly reduce early wave reflection, we explored the effects of a single oral dose of sildenafil citrate (50 mg) on blood pressure and arterial wave reflection in treated hypertensive men in a single-blind randomised placebo controlled crossover study. Eight men (aged 57-76 years) with well controlled hypertension and erectile dysfunction and no contraindications to the use of sildenafil, were given either sildenafil 50 mg or placebo orally, with the second drug being given 2 weeks later. Blood pressure and heart rate with an automated digital oscillometric device (Omron  HEM-705 CP) and the augmentation index, a measure of arterial wave reflection in the aorta derived using radial applanation tonometry, were measured before and at 15-min intervals for 2 h thereafter. The extent of individual
Introduction
Sildenafil, a selective inhibitor of phosphodiesterase type 5, is now widely used in the treatment of erectile dysfunction. Post marketing surveillance initially revealed a number of serious cardiovascular events, including 69 deaths reported to the Food and Drug Administration (FDA) temporally associated with the use of sildenafil 1 which raised questions about possible adverse cardiovascular effects. A recent commentary in the Journal of Human Hypertension has drawn attention to these and other answered questions. 2 Since then a further analysis of spontaneous reports to the FDA up to February 1999 shows 401 deaths (219 cardiac, 140 sudden) over 10-11 months in 4 -5 million men or 8.5 deaths/million men/month which is well within the expected rate for such patients. 3 Data from a preliminary review of 5000 users in England yields a standardised mortality ratio from ischaemic heart disease at 30% lower than expected. 4 Marked hypotension has been noted when sildenafil was used concomitantly with nitrates. In addition sildenafil may itself have a hypotensive effect. In healthy subjects, sildenafil 50 mg decreased blood pressure (mm Hg) by a mean of 7.7 systolic, 4.5 diastolic, and in addition decreased forearm vascular resistance. 5 This suggests that the vasodilatory effects of sildenafil are not confined to penile vasculature. While sildenafil has been given to hypertensive patients without adverse consequence, those were largely on monotherapy and the recent American College of Cardiology/American Heart Association consensus statement 1 draws attention to potential hazards in patients on multidrug antihypertensive therapy and advises 'until adequate studies are done in these subgroups sildenafil should be prescribed with caution'. The actions of sildenafil are in part mediated through enhancement of the effects of nitric oxide. 6, 7 Nitrates given acutely markedly alter the aortic pressure waveform reducing aortic blood pressure, delaying wave reflections in the aorta and reducing arterial stiffness. 8 The aorta and large arteries serve a major function in the cardiovascular system as a conduit and buffering organ and their impairment plays an important role in the pathogenesis of cardiovascular disease. Increased arterial stiffness is associated with a number of risk factors, including smoking, hypertension, diabetes, hypercholesterolaemia and atherosclerosis. 9 Large arteries buffer the pressure changes resulting from intermittent ventricular ejection of blood into the aorta. By absorbing a proportion of the energy in systole and releasing it in diastole, not only do they maintain coronary blood flow but also avoid an increase in left ventricular afterload while smoothing out blood flow to the periphery. Pressure waves are reflected back from the periphery and summate with the forward-going wave to produce the characteristic aortic pressure waveform. When the ventricular-vascular coupling is optimal, the reflected waves fall in the diastolic portion of the arterial pressure wave and so do not influence aortic systolic pressure but enhance coronary blood flow. 10, 11 However, with vascular stiffening, pulse wave velocity and the amplitude of the reflected waves both increase, such that the reflected wave arrives earlier and augments central systolic pressure. Thus early wave reflection elevates systolic and pulse pressure and impedes coronary perfusion.
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The technique of pulse wave analysis can be used to assess aortic blood pressure. 12 Peripheral arterial pressure waveforms from the radial artery may be recorded non-invasively by applanation tonometry 13 and by applying a validated integral transfer function, 14 the aortic pressure waveform can be derived. In particular, aortic pressures can be measured and the augmentation index calculated, as a measure of arterial wave reflection. A high index is closely related to aortic stiffness. 15 Nitrates offset the ill effects of early wave reflection by reducing the intensity of wave reflection in man and decreasing systolic pressure in the aorta. 16 We hypothesised that sildenafil which effected a fundamental regulator of vascular tone would be expected to have systemic effects on arterial function. We therefore studied the effects of sildenafil on blood pressure and early wave reflection in treated hypertensive men, including those on multi-drug regimens, who requested sildenafil.
Materials and methods

Patients
Eight men aged 57-65 years, with erectile dysfunction for 1-6 years and hypertension (initial diagnosis Ͼ140/90 mm Hg and ambulatory 24 h Ͼ135/ 85 mm Hg) for more than 1 year on chronic antihypertensive therapy, four monotherapy, three on dual therapy, one on five agents (amlodipine 5, diuretic 4, ACE inhibitor 3, angiotensin receptor antagonist 2, diltiazem 1) participated in this study. A secondary cause was not discovered in any of the patients. None had overt coronary heart disease or were receiving nitrates. Three patients had previous cerebrovascular events, one atrial fibrillation and one had dietary controlled non-insulin dependent diabetes mellitus. Concomitant prescriptions included aspirin (3), warfarin (2) and pravastatin (2). Erectile dysfunction was attributed to the underlying vascular events, diabetes and psychological causes. The withdrawing of diuretics had not been effective. The patients gave informed consent and the institutional ethics committee approved the study.
Study design
While maintaining their antihypertensive medications, patients were given orally either sildenafil 50 mg or placebo in a randomised single-blind crossover fashion on two separate occasions, at least 15 days apart. Doses of all medication was unchanged and given at the same time some 4 h before sildenafil/placebo on both study days. The haemodynamic measurements were carried out in the supine position in a quiet room at room temperature of 20°Ϯ 0.5°C. Blood pressure, heart rate and augmentation index were measured at baseline and at 15-min intervals for 2 h following sildenafil or placebo. Adverse events were recorded at both study visits. The primary haemodynamic measurements were made at 60-90 min following placebo/ sildenafil when peak drug levels are achieved.
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Blood pressure and heart rate measurements Blood pressure was measured with an automated digital oscillometric device (Omron  Model HEM-705CP) to avoid observer bias. Each reading was taken immediately before pulse wave analysis. The heart rate was recorded at baseline and every 30 min for 2 h following sildenafil/placebo by a 12-lead electrocardiogram.
Derivation of the arterial pressure waveform
The aortic blood pressures and the augmentation index in the aorta were measured by pulse wave analysis using Sphygmocor  (BPAS-1, PWV Medical  , Sydney, Australia). A high fidelity micromanometer (SPC-301: Miller Instruments, TX, USA) was used to flatten the radial artery. When the surfaces are flattened, circumferential pressures are equalised and an accurate pressure waveform can be recorded; this technique is termed applanation tonometry. The software allowed on-line recording of the peripheral waveform. After 20 sequential waveforms had been acquired, the integral software was used to generate an average peripheral and corresponding aortic waveform. The aortic waveform Figure 1 Waveform printout of one of the study subjects showing exaggerated early wave reflection P 1 : early systolic peak which corresponds to the time of peak flow or ejection P 2 : late systolic peak is caused by wave reflection. The augmentation index is defined as the difference between the early and late systolic peaks (⌬P) expressed as a percentage of pulse pressure (PP).
was then analysed further to determine the augmentation index which is defined as the difference between the first (P 1 ) and second peaks (P 2 ) of the aortic pressure waveform, expressed as a percentage of pulse pressure, and the left ventricular ejection duration was measured from the foot of the pressure wave to the diastolic incisura. Figure 1 describes how the augmentation index is derived from the aggregated aortic pulse waveform. The method has been validated and found highly reproducible.
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Statistical analysis
Brachial blood pressures, aortic blood pressures, augmentation index and heart rate were analysed using two approaches:
(1) Deriving the area under the effect curve following sildenafil or placebo which was calculated using the trapezoidal rule from the baseline readings on the individual study days. (2) Analysing individual data following 75 min which has been shown to correlate with the time of peak blood levels, and also the extent of maximal reduction in blood pressure again corrected to the individual baseline values on each study day.
These data were analysed by ANOVA for repeated measures and Wilcoxon rank sum test. Correlations were examined by linear regression analysis. All results are expressed as mean Ϯ s.e.m. and P Ͻ 0.05 considered significant.
Results
Although blood pressure varied throughout on both study days ( Figure 2 ) the lowest readings were seen with sildenafil. There were significant reductions in systolic and diastolic blood pressure as recorded in the brachial artery (peripheral) and aorta (central) following sildenafil. The extent of individual maximum reductions from baseline in brachial systolic blood pressure (24 Ϯ 10 vs 6 Ϯ 8, P Ͻ 0.05) The shape of the radial and aortic pressure waveform was changed (Figure 3 ; height of the late systolic peak reduced) by sildenafil. The augmentation index, a measure of wave reflection was lower (Figure 4 ) at 90 min (P Ͻ 0.05). For the entire 120 min the area under the blood pressure, both brachial and aortic, and augmentation index time curve (by the trapezoidal rule corrected for baseline reading) was significantly lower (P Ͻ 0.05) with sildenafil ( Figures 2 and 4) . There was no correlation between the extent of fall in blood pressure and the extent of fall in augmentation index.
Despite a pressure of 90/66 mm Hg on treatment with sildenafil and another patient exhibiting a 48/23 mm Hg fall, none complained of hypotensive symptoms although two had flushing and nasal congestion. No significant change in left ventricular ejection duration or heart rate was noted (Figure 4 ).
Discussion
Sildenafil in now frequently prescribed for men with erectile dysfunction irrespective of its aetiology which is often difficult to diagnose with certainty. 2 The relaxation of vascular smooth muscle in the corpus cavernosum that is essential for penile erection is mediated by nitric oxide (NO), which activates guanylate cyclase to produce cGMP, decreasing intracellular calcium. Sildenafil, a highly selective inhibitor of phosphodiesterase type 5, responsible for the degradation of cGMP, enhances the effects of NO, endogenous or exogenous. The actions of nitroglycerin and other NO donors are mediated via the NO-cGMP pathway, after their conversion or release of NO. NO decreases systemic vascular resistance and blood pressure in healthy humans. Exogenously acting nitrates, acting through NO-cGMP pathway can also cause modest reduction in systemic blood pressure. Nitrates in addition have shown to improve arterial compliance and also have shown a marked reduction in the intensity of early wave reflection in the aorta despite no change in systemic blood pressure. 16 Our results show that sildenafil 50 mg acutely lowers blood pressure, both brachial and aortic, without a compensatory rise in heart rate. The hypotensive effects could be direct or secondary to a drug interaction. Also we found an effect of sildenafil on arterial wave reflection. 
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Effect of sildenafil on brachial blood pressure
Blood pressure fluctuated on both study days and there was a marked variation in the time and extent of maximal fall in blood pressure with sildenafil. In one individual there was a reduction of 48/23 mm Hg but in this and other studies 20,21 hypotensive symptoms were not seen. We used a validated oscillometric device to record blood pressure. While a recent study 22 suggested that another type of oscillometric monitor may give higher readings than a random zero sphygmomanometer. The latter is not without problems and as the same device was used throughout our study we believe the findings are valid.
This study shows that in comparison to placebo, sildenafil has a significant effect on blood pressure in treated hypertensive men (Figure 2) . In healthy male volunteers administration of a single dose of up to 200 mg did not produce 'clinically' significant effects on resting heart rate or blood pressure, 1, 17 nonetheless in other volunteer studies sildenafil produced a transient modest reduction in systolic (8-10 mm Hg) and diastolic (5-6 mm Hg) blood pressures. The peak effect occurred at 1 h after dose, coincident with peak plasma concentrations, and blood pressure returned to baseline about 4 h after dose. 1 The hypotensive effect appears to be neither age dependent nor dose related. In normal volunteers intravenous administration of 20-80 mg produced a significant decrease in vascular resistance and systemic vascular resistance index. Sildenafil has been noted to have both arteriodilator and venodilator effects on the peripheral vasculature. In eight patients with stable angina, sildenafil reduced systemic and pulmonary artery pressures and cardiac output consistent with mixed arterial and venous vasodilatory effects. More recently in 14 men with severe coronary artery disease a significant reduction in systemic arterial and pulmonary arterial pressure was seen without any effect on pulmonary wedge pressure, cardiac output or coronary blood flow.
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Effect of sildenafil on aortic blood pressure
Sildenafil significantly decreased both systolic and diastolic blood pressures in the aorta as compared to placebo. The peak effect occurred at 75 min after the administration of sildenafil. Though the number of subjects is small, there is a suggestion that the fall in the aortic systolic pressures might be more than that in the brachial artery (Figure 2 ) which however, did not reach statistical significance. This preferential effect on the aortic pressures compared to the brachial pressures is well known for nitrates. 16 
Effect of sildenafil on heart rate
Despite an overall reduction in blood pressure and marked fall of blood pressure in individual subjects, heart rate was unchanged. In clinical practice dizziness (2%) and postural hypotension at less than 2% have been reported rarely and at a similar rate to placebo treated patients. 1, 17 While flushing is commonly reported with sildenafil (10 times more frequently than with placebo) tachycardia or palpiJournal of Human Hypertension tations are not more frequent. 1, 17, 20 In an interaction study with glyceryl trinitrate, for a fall in systolic blood pressure of greater than 25 mm Hg the change in heart rate was negligible. 23 Of interest, a recent study has shown that sildenafil 100 mg in normotensive subjects causes a marked increase in sympathetic activity, both at rest and during stressful stimuli.
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Drug interactions with sildenafil
Interactions between drugs are either kinetic or dynamic in origin. While sildenafil is metabolised mainly by cytochrome P450 and particularly CYP3A4, drugs that inhibit this enzyme including cimetidine and erythromycin may increase its level in blood. A recent pharmacoepidemiological study has shown that the prescribers are careful in avoiding co-prescribing with interacting drugs particularly nitrates. 25 We are unaware that any of the antihypertensive drugs in our study, calcium channel blockers, diuretics, ACE inhibitors or concomitant therapy have such an effect. In an interaction study with the calcium antagonist, amlodipine 23 in hypertensive men, the mean maximal reduction in blood pressure with sildenafil 100 mg was some 8/7 mm Hg greater in comparison with placebo. A similar pharmacodynamic interaction has been seen with another calcium antagonist lercanidipine. 26 The pharmacokinetics of neither amlodipine nor lercandipine were altered in these studies. We have now shown a fall in blood pressure of somewhat greater magnitude in patients on a variety of antihypertensives which is in keeping with a direct hypotensive effect of sildenafil.
The cardiovascular response to sexual activity has recently been reviewed. 27 Initial studies by Masters and Johnson with young subjects in laboratory conditions, reported heart rate and blood pressure responses at near maximum exercise levels that do not reflect the less strenuous (moderate exercise) response seen in more recent studies using ambulatory recordings in middle aged men. A modest blood pressure lowering effect of sildenafil during sexual intercourse, which usually produces systolic blood pressure in the region of 150-180 mm Hg, 28 may explain why hypotensive symptoms have not been commonly reported. On the other hand in untreated hypertensives (155/87 mm Hg) during coitus the heart rate reached 124 beats per min and systolic blood pressure increased by 50%. Overall the risk of myocardial infarction after sexual activity is very low from 0.01% over a year for low risk individuals engaging in weekly sexual activity to 0.1% for high risk individuals.
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Effect of sildenafil on arterial wave reflection
As arteries stiffen, especially in hypertension, pulse wave velocity increases and the localisation of the sites of wave reflection may move proximally causing the reflected wave to increase in amplitude and return to the ascending aorta earlier, during systole. 11 The augmentation index, a measure of early wave reflection, was significantly elevated in our subjects which is compatible with the degree of arterial stiffness seen in hypertension. 12, 30 We believe our data suggests a direct effect of sildenafil on large artery function. We noticed a change in the arterial pressure waveform ( Figure 3 ) and a significant fall in the augmentation index. We did not see any relationship between the extent of fall in blood pressure and fall in augmentation index although the study was not sufficiently powered to examine blood pressure independent effects. Also not all antihypertensives have a beneficial effect on arterial stiffness in reducing arterial wave reflection despite the same level of blood pressure reduction. 31, 32 ACE inhibitors, but not alpha or conventional beta-blockers have been shown to reduce arterial wave reflection. Sildenafil significantly reduced early wave reflection and by inference arterial stiffness. Furthermore nitrates markedly reduce early wave reflection and have a preferential effect on aortic more than peripheral blood pressure. 8, 16 The fall in augmentation index seen with sildenafil could be due to a number of mechanisms, eg delaying wave reflections by decreasing pulse wave velocity, shorter left ventricular ejection duration or by reducing the intensity of wave reflections. The reduction in augmentation index could be due to a decrease in pulse wave velocity which was not measured in the present study. However in vitro studies have shown little vasodilatory effect of sildenafil on the aorta unless combined with nitrates. 33 The left ventricular ejection duration did not show any significant change. A decreased augmentation index could also be due to reduction in the intensity of wave reflection. Sildenafil increases cGMP levels in muscular arteries in vitro and decreases forearm vascular resistance in healthy humans. 5 The principal sites of wave reflection are where small muscular arteries terminate in high resistance arterioles. Clinical studies have shown that wave reflection intensity can be reduced by drugs that dilate small peripheral conduit arteries. 34 A direct effect of sildenafil on the vascular smooth muscle in the small muscular arteries could lead to vasodilatation and decrease in the amplitude of wave reflection. The extent of the effect of sildenafil on arterial wave reflection was in part independent of alterations in blood pressure. The most likely mechanism of sildenafil is a direct effect on vascular smooth muscle cells in the small muscular arteries, increasing nitric oxide in the vessel wall and causing active vasodilatation, leading to a reduction in amplitude of wave reflection in the aorta.
Nitric oxide decreases systemic vascular resistance and blood pressure in man. 35 While sildenafil preferentially inhibits PDE5 which is concentrated in the genitalia, it is also found throughout the systemic vasculature. 33 Also in vivo sildenafil has been shown in cardiac tissue to increase cyclic adenosine monophosphate (cAMP) which has vasodilatory effects and there is evidence of 'cross talk' between cGMP and cAMP-dependent signal transduction pathway. 36 The effect of sildenafil on arterial function seen in this study is not, therefore unexpected. It does however point to additional therapeutic targets for inhibition of PDE5.
